X

Medical Cannabis

Cronos Group (CRON) Earnings: 4Q20 Key Numbers

Cronos Group Inc. (NASDAQ: CRON) reported fourth quarter 2020 earnings results today. Net revenue more than doubled year-over-year to $17…

Tilray Inc (TLRY) Q4 2020 Earnings Call Transcript

Tilray Inc  (NASDAQ: TLRY) Q4 2020 earnings call dated Feb. 17, 2021. Corporate Participants: Raphael Gross -- Investor Relations Brendan…

HEXO Corp. (HEXO) Earnings: 1Q21 Key Numbers

HEXO Corp. (NYSE: HEXO) reported its first quarter 2021 earnings results today. Net revenue rose 103% year-over-year to CAD29.5 million.…

Canopy Growth Corporation (CGC) Q2 Earnings: Key financials and quarterly highlights

Canopy Growth Corporation (NYSE: CGC) reported second quarter 2021 earnings results today. Net revenues increased 77% year-over-year to CAD135.3 million,…

HEXO Corp (HEXO) Earnings: 4Q20 Key Numbers

HEXO Corp (NYSE: HEXO) reported net revenue of CAD27.1 million for the fourth quarter of 2020, reflecting an increase of…

Aurora Cannabis (ACB) banks on premium brands after disastrous Q4

Shareholders of Aurora Cannabis (NYSE: ACB) were dealt an unexpected blow this week as the pot company's disappointing earnings report…

During tough times, Tilray (TLRY) looks overseas to achieve growth targets

Cannabis was recognized as an essential business in several markets when the shutdown came into effect, including Canada and some…

GW Pharmaceuticals PLC (GWPH) Q2 2020 Earnings Call Transcript

GW Pharmaceuticals PLC (NASDAQ: GWPH) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Stephen Schultz -- Vice President of Investor…

Canopy Growth’s (CGC) net loss narrows in Q1 on revenue growth and cost cuts; stock surges

After Canopy Growth (NYSE: CGC) reported its first quarter 2021 results yesterday, the shares jumped about 10% in the pre-market…

Tilray Q2 loss widens despite revenue growth; results miss

https://www.youtube.com/watch?v=KqNZ-_X4F8k&t=2s Cannabis company Tilray, Inc. (NASDAQ: TLRY) Monday reported a wider net loss for the second quarter of 2020, despite…

Canopy Growth (CGC) Q1 2021 earnings in a nutshell

Canopy Growth (NYSE: CGC) reported an improvement in net loss for its first quarter ended 2021 with a revenue increase…

Cronos (CRON) Q2 Earnings: Key financials and quarterly highlights

Cronos Group Inc. (NASDAQ: CRON) reported second quarter 2020 earnings results today. Consolidated net revenues grew 29% year-over-year to $9.9…

Aphria (APHA) swings to a loss in Q4 despite 18% growth in revenue

Aphria (NASDAQ: APHA) stock plunged more than 10% in the pre-market trading session as it reported a loss of C$98…

HEXO Corp. (NYSE: HEXO) Q3 2020 Earnings Call Transcript

HEXO Corp. (HEXO) Q3 2020 earnings call dated June 11, 2020 Corporate Participants: Jennifer Smith -- Director of Investor Relations Sebastien St-Louis -- Co-founder…

Infographic: Key highlights of HEXO Corp (HEXO) Q3 2020 earnings

HEXO Corp. (TSX: HEXO; NYSE: HEXO) reported a wider loss in the third quarter of 2020 due to higher expenses.…

Infographic: Highlights of Canopy Growth (CGC) Q4 2020 earnings results

Canopy Growth Corporation (NYSE: CGC) reported its financial results for the quarter ended March 31, 2020, on Friday before the…

Village Farms (VFF): Regulatory uncertainty – a major roadblock for US CBD opportunity

Village Farms International Inc. (NASDAQ: VFF) reported total sales of $39.6 million for the first quarter of 2020 compared to…

Aurora Cannabis Inc  (NYSE: ACB) Q3 2020 Earnings Call Transcript

Aurora Cannabis Inc  (ACB) Q3 2020 earnings call dated May 14, 2020 Corporate Participants: Michael Singer -- Executive Chairman and Interim Chief…

Infographic: Highlights of Aurora Cannabis (ACB) Q3 2020 Earnings Report

Aurora Cannabis, Inc. (NYSE: ACB) reported a narrower loss for the third quarter of 2020, aided by a 16% growth…

Tilray’s (TLRY) loss widens in Q1 despite minimal impact from COVID-19

Tilray (NASDAQ: TLRY) reported mixed results yesterday for its first quarter of 2020. Despite revenue rising more than 100% in…

GW Pharmaceuticals (GWPH): Investments in manufacturing and international expansion serve as strong growth drivers

GW Pharmaceuticals plc (NASDAQ: GWPH) has seen its stock gain over 17% in the past one month. The company delivered…